Eugene Tan

587 total citations
20 papers, 413 citations indexed

About

Eugene Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Eugene Tan has authored 20 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Eugene Tan's work include Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Eugene Tan is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Eugene Tan collaborates with scholars based in United States, Australia and Spain. Eugene Tan's co-authors include William H. Bay, J. Mendell, J Neff, James A. Whitlock, Christopher L. Moertel, Lisa Osterloh, Éric Bouffet, Elizabeth Fox, Darren Hargrave and Isabelle Aerts and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and British Journal of Cancer.

In The Last Decade

Eugene Tan

20 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eugene Tan United States	9	140	109	103	83	68	20	413
Jessica Boklan United States	12	215 1.5×	78 0.7×	118 1.1×	55 0.7×	62 0.9×	30	467
William Koss United States	9	139 1.0×	53 0.5×	157 1.5×	84 1.0×	46 0.7×	19	426
Leonie Frauenfeld Germany	10	128 0.9×	58 0.5×	113 1.1×	165 2.0×	38 0.6×	26	517
Yu-Kai Su Taiwan	10	162 1.2×	53 0.5×	94 0.9×	57 0.7×	55 0.8×	14	340
Yasushi Otani Japan	10	149 1.1×	140 1.3×	383 3.7×	171 2.1×	78 1.1×	19	607
Pablo Berlanga France	12	186 1.3×	140 1.3×	181 1.8×	167 2.0×	35 0.5×	54	492
Bobin Chen China	12	104 0.7×	239 2.2×	125 1.2×	43 0.5×	121 1.8×	66	501
Hidenori Kasahara Japan	9	203 1.4×	21 0.2×	137 1.3×	44 0.5×	60 0.9×	21	476
Margaret Ottaviano Italy	11	153 1.1×	98 0.9×	193 1.9×	71 0.9×	16 0.2×	62	450
Yuhan Huang United States	9	262 1.9×	30 0.3×	248 2.4×	62 0.7×	23 0.3×	24	568

Countries citing papers authored by Eugene Tan

Since Specialization

Citations

This map shows the geographic impact of Eugene Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Tan more than expected).

Fields of papers citing papers by Eugene Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Tan. The network helps show where Eugene Tan may publish in the future.

Co-authorship network of co-authors of Eugene Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Tan. A scholar is included among the top collaborators of Eugene Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Tan. Eugene Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tan, Eugene, et al.. (2024). Can lithium be used in the setting of clozapine commencement in patients with COVID ‐19 associated neutropenia: A case report. SHILAP Revista de lepidopterología. 12(4). e8758–e8758. 1 indexed citations

Song, Yunmei, Sadikalmahdi Abdella, Franklin Afinjuomo, et al.. (2023). Physicochemical properties of otic products for Canine Otitis Externa: comparative analysis of marketed products. BMC Veterinary Research. 19(1). 39–39. 2 indexed citations

Song, Yunmei, Candace M. Day, Franklin Afinjuomo, et al.. (2023). Advanced Strategies of Drug Delivery via Oral, Topical, and Parenteral Administration Routes: Where Do Equine Medications Stand?. Pharmaceutics. 15(1). 186–186. 13 indexed citations

Bouffet, Éric, Birgit Geoerger, Christopher L. Moertel, et al.. (2022). Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma. Journal of Clinical Oncology. 41(3). 664–674. 89 indexed citations

Modi, Natansh D., Eugene Tan, Andrew Rowland, et al.. (2021). The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data. npj Breast Cancer. 7(1). 32 indexed citations

Braña, Irene, Geoffrey I. Shapiro, Melissa L. Johnson, et al.. (2021). Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). 3005–3005. 47 indexed citations

Tan, Eugene, Ahmad Y. Abuhelwa, Natansh D. Modi, et al.. (2021). Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab. Bladder Cancer. 8(1). 81–88. 6 indexed citations

Modi, Natansh D., Eugene Tan, Andrew Rowland, et al.. (2020). The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data. Frontiers in Oncology. 10. 12 indexed citations

Alenazy, Rawaf, Yinhu Wang, Rumana Mowla, et al.. (2019). Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance. Bioorganic & Medicinal Chemistry Letters. 29(7). 882–889. 11 indexed citations

10.

Weger, Vincent A. de, Sanjay Goel, Roger von Moos, et al.. (2017). A drug–drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 81(1). 73–80. 4 indexed citations

11.

Sarantopoulos, John, Sanjay Goel, Vincent Chung, et al.. (2016). Randomized phase 1 crossover study assessing the bioequivalence of capsule and tablet formulations of dovitinib (TKI258) in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 78(5). 921–927. 1 indexed citations

12.

Infante, Jeffrey R., Ramesh K. Ramanathan, Daniel J. George, et al.. (2015). A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258). Cancer Chemotherapy and Pharmacology. 75(4). 729–737. 4 indexed citations

13.

Quintela-Fandiño, Miguel, María J. Bueno, Luís Lombardía, et al.. (2014). Selective activity over a constitutively active RET‐variant of the oral multikinase inhibitor dovitinib: Results of the CNIO‐BR002 phase I‐trial. Molecular Oncology. 8(8). 1719–1728. 3 indexed citations

14.

Kang, Y-K., Changhoon Yoo, B-Y. Ryoo, et al.. (2013). Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib. British Journal of Cancer. 109(9). 2309–2315. 49 indexed citations

15.

Dubbelman, Anne-Charlotte, et al.. (2012). Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 70(5). 653–663. 16 indexed citations

16.

Garonzik, Samira M., et al.. (2012). Dovitinib (TKI258): Exploration of pharmacokinetics and pharmacodynamics (PK/PD) for dose and regimen consideration.. Journal of Clinical Oncology. 30(15_suppl). 2603–2603. 1 indexed citations

17.

Huang, Tao, Guohui Ding, Yixue Li, et al.. (2010). Dysfunctional gene/protein networks in hepatitis C virus-induced hepatocellular cirrhosis and carcinoma. 502–507. 4 indexed citations

18.

Chen, Qing, Eugene Tan, John R. Strauss, et al.. (2004). Effect of Quinidine on the 10-Hydroxylation of R-Warfarin: Species Differences and Clearance Projection. Journal of Pharmacology and Experimental Therapeutics. 311(1). 307–314. 2 indexed citations

19.

Tan, Eugene, et al.. (1993). Acute Renal Failure Resulting From Intravenous Immunoglobulin Therapy. Archives of Neurology. 50(2). 137–139. 112 indexed citations

20.

Tan, Eugene, Antanas Butkus, & Simon Koletsky. (1976). Hepatic cholesterol metabolism in vitro in the obese spontaneously hypertensive, hyperlipemic and atherosclerotic rat. Experimental and Molecular Pathology. 25(2). 142–151. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact